FPGS and colorectal carcinoma: Furthermore, FPGS deficiency has been linked to resistance to 5-FU in models of CRC (Sohn et al, 2004), illustrating the need for novel intervention strategies to prevent relapses caused by drug-resistant, polyglutamylation-deficient cells.